Pharmaceuticals · 2022 · 26 citations · 34 references
PharmacyPharmaceuticsPharmacologyBioavailabilityDrug DeliveryNanoparticle Drug DeliveryCholesterol MetabolismNanocarriers For TherapeuticsNanomaterials For Drug DeliveryNanoparticle-based BioavailabilityOral NanocarriersPermeability OptimizationCholesterol EffluxEntrapmentHmg-coa Reductase InhibitorsHmg-coa Reductase RegulationLow-density Lipoprotein Cholesterol LoweringParticle DiffusionTransdermal Delivery SystemsTransdermal Drug Delivery Systems
Gambir (Uncaria gambir, Roxb.) contains catechins that is often empirically used to treat various diseases. Catechins can reduce cholesterol levels by inhibiting coenzyme HMG-CoA reductase that plays a role in cholesterol metabolism. Research has been carried out covering the optimization of transethosomal catechins, the formulation of Transethosomal Catechin Gel (TCG) and Non-Transethosomal Catechin Gel (NTCG), which were then tested for catechin permeation from these gel preparations in vitro using Franz’s diffusion cell with PTFE membranes. The anti-hypercholesterol activity test was carried out with Simvastatin orally as a positive control using 25 male Wistar rats (Rattus norvegicus). The catechin transetosomes have a size of 176.1 ± 5.8 nm, Zeta potential −11.6 ± 5.28, and Entrapment Efficacy of 96.77% ± 0.05. The result of cumulative catechins that permeated from TCG and NTCG were and 172.454 ± 5.287 and 112.741 ± 2.241 μg respectively. Permeation test graphs showed similar permeation and flux profiles. TCG can reduce total cholesterol and LDL (Low Density Lipoprotein) values in rats by 39.77% and 51.52% respectively during 14 days of use.
34
Andreia Ascenso, Cátia Batista, Pedro J. S. Cardoso et al. · International Journal of Nanomedicine · 2015 · 371 citations · Full text
Epidemiology and management of hyperlipidemia.
Samantha Karr · PubMed · 2017 · 370 citations